https://www.live-feeds.com/feed/it-now-seems-possible-to-vaccinate-against-cancerContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/it-now-seems-possible-to-vaccinate-against-cancerhttps://www.live-feeds.com/feed/it-now-seems-possible-to-vaccinate-against-cancer#u51436Sat, 29 Aug 2026 07:20:34 +0000A positive trial for a Moderna cancer vaccine provides hope for treating patients, though researchers emphasize that more work is required to move these effective vaccines into clinical settings. This follows previous findings that a personalized mRNA vaccine, used alongside Keytruda, prevents melanoma from spreading or returning in high-risk patients after surgery. While these results show potential for long-term cancer-free survival, the current focus is on accelerating the development of personalized therapies to make them widely available to the public.Why it mattersThe development of thes https://www.live-feeds.com/feed/it-now-seems-possible-to-vaccinate-against-cancerhttps://www.live-feeds.com/feed/it-now-seems-possible-to-vaccinate-against-cancer#u49028Wed, 26 Aug 2026 09:26:04 +0000An experimental personalized mRNA vaccine developed by Moderna and Merck prevents melanoma from returning or spreading in high-risk patients. When paired with the drug Keytruda, the treatment helps patients stay cancer-free longer following surgery. This result follows a decade of development characterized by logistical hurdles and pandemic-era obstacles. Separate research into mRNA molecules also shows potential for remodeling the immune system to generate T cells capable of slowing or eradicating tumor growth.Why it mattersMelanoma is a high-risk skin cancer prone to recurrence after surgica https://www.live-feeds.com/feed/it-now-seems-possible-to-vaccinate-against-cancerhttps://www.live-feeds.com/feed/it-now-seems-possible-to-vaccinate-against-cancer#u46971Sun, 23 Aug 2026 14:56:33 +0000Moderna's melanoma vaccine, developed with Merck, has shown promising results in a large trial, potentially paving the way for cancer vaccination. The vaccine, designed to prevent skin cancer recurrence, has sparked optimism about its effectiveness. This development could lead to a new approach in cancer treatment.Why it mattersThe fight against cancer has seen significant advancements, with vaccination emerging as a potential strategy. Moderna's success with its COVID-19 vaccine has translated to cancer research, with the company's melanoma vaccine demonstrating encouraging res